Protocol for a Pragmatic Trial of Pharmacotherapy Options Following Unsatisfactory Initial Treatment in OCD (PROCEED)

BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) are the first-line pharmacotherapy for obsessive-compulsive disorder (OCD), but a large proportion of patients do not achieve remission after an adequate SSRI trial. To the best of our knowledge, there have been no well-powered randomized c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Pei, Gu, Wenjie, Gao, Jian, Wang, Changhong, Fang, Jianqun, Hu, Maorong, Xiang, Hui, Li, Bin, Liu, Na, Tang, Wenxin, Wang, Xijin, Jia, Yanbin, Li, Yi, Cheng, Yuqi, Tang, Zhen, Simpson, Helen Blair, Stein, Dan J., Wang, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150605/
https://www.ncbi.nlm.nih.gov/pubmed/35651818
http://dx.doi.org/10.3389/fpsyt.2022.822976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150605/
https://www.ncbi.nlm.nih.gov/pubmed/35651818
http://dx.doi.org/10.3389/fpsyt.2022.822976

Ejemplares similares